Skip to main content
Pure Biologics S.A. logo

Pure Biologics S.A. — Investor Relations & Filings

Ticker · PUR ISIN · PLPRBLG00010 LEI · 2594002TXS19AUYHIF82 WAR Manufacturing
Filings indexed 511 across all filing types
Latest filing 2026-05-29 Interim / Quarterly Rep…
Country PL Poland
Listing WAR PUR

About Pure Biologics S.A.

https://purebiologics.com/

Pure Biologics S.A. is a biopharmaceutical company engaged in the discovery and development of novel biological drugs and non-systemic therapies. The company leverages its expertise in antibody and aptamer technologies to create innovative treatments. Its therapeutic portfolio is primarily focused on immuno-oncology. A key aspect of its strategy is the development of original, non-generic and non-biosimilar, biological drug candidates.

Recent filings

Filing Released Lang Actions
Śródroczne skrócone sprawozdanie finansowe Pure Biologics SA za okres 1.01-31.03.2026
Interim / Quarterly Report Classification · 96% confidence The document is a full interim condensed financial report (“Śródroczne Skrócone Sprawozdanie Finansowe”) for the period 01.01–31.03.2026. It includes complete financial statements (income statement, balance sheet, cash flows, statement of changes in equity) and explanatory notes, covering a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-29 Polish
Jednostkowy raport kwartalny Pure Biologics SA za 1Q 2026
Interim / Quarterly Report Classification · 93% confidence The document is titled “Jednostkowy raport kwartalny za okres 01.01.2026 – 31.03.2026 r.”, contains detailed interim results, selected financial data, a condensed financial statement, management commentary, and covers a quarter shorter than a full fiscal year. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-29 Polish
Sprawozdanie niezależnego biegłego rewidenta z badania rocznego sprawozdania finansowego za rok 2025 - podpis
Regulatory Filings
2026-05-15 Polish
Sprawozdanie niezależnego biegłego rewidenta z badania rocznego sprawozdania finansowego za rok 2025
Regulatory Filings
2026-05-15 Polish
Jednostkowe sprawozdanie finansowe za okres 01.01-31.12.2025 - podpisy
Regulatory Filings
2026-05-15 Polish
Jednostkowe sprawozdanie finansowe za okres 01.01-31.12.2025
Regulatory Filings
2026-05-15 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.